A similar association was seen with activating mutations of ACVR1, where 20 and 25 % of patients with GBM and AA histology had these mutations, respectively, whereas grade II DIPG and DIPG with PNET histology did not harbour ACVR1 mutations. The gene discussed is ACVR1; the disease is glioblastoma.